Lobe Sciences Ltd.
LOBEF
Rank in Stocks
#29141
Lobe Sciences Ltd. operates as a life sciences entity, primarily focused on the... Lobe Sciences Ltd. operates as a life sciences entity, primarily focused on the exploration and advancement of psychedelic pharmaceutical compounds. The company is actively engaged in formulating psilocybin-derived therapeutics, combined with N-acetylcysteine, intended for the treatment of mild traumatic brain injuries and post-traumatic stress disorder. Beyond drug development, it also engineers specialized devices designed to facilitate the efficient delivery of various medications. The organization was previously known as Greenstar Biosciences Corp. before formally changing its name to Lobe Sciences Ltd. in November 2020. Its main corporate office is situated in Vancouver, Canada.
Share Price
$0.0287
Last synced: 2026-11-09
Market Cap
$8.73M
Change (1 day)
7.49%
Change (1 year)
-18.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Lobe Sciences Ltd. (LOBEF)
Category
Healthcare
EPS for Lobe Sciences Ltd. (LOBEF)
EPS as of May 2026 TTM: $-0.01
According to Lobe Sciences Ltd.'s latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2025 the company had an EPS of $-0.02, an increase over its 2024 EPS of $-0.03.
EPS history for Lobe Sciences Ltd. from 2011 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.01 | -26.50% |
| 2025 | $-0.02 | -13.43% |
| 2024 | $-0.03 | -19.76% |
| 2023 | $-0.03 | -86.28% |
| 2022 | $-0.24 | 2.40% |
| 2021 | $-0.24 | 3.35% |
| 2020 | $-0.23 | 224.54% |
| 2019 | $-0.07 | -62.84% |
| 2017 | $-0.19 | 220.13% |
| 2016 | $-0.06 | -65.55% |
| 2015 | $-0.17 | 34.00% |
| 2014 | $-0.13 | -27.72% |
| 2013 | $-0.18 | 11.00% |
| 2012 | $-0.16 | -86.07% |
| 2011 | $-1.16 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | -44,327.21% |
DE
|
|
| $6.08 | -41,444.22% |
DE
|
|
| $1.55 | -10,648.30% |
JP
|
|
| $3.66 | -24,997.96% |
CH
|
|
| $0.45 | -3,161.22% |
IL
|
Questions about Lobe Sciences Ltd.'s earnings per share (EPS)
What is Lobe Sciences Ltd.'s earnings per share (EPS)?
Lobe Sciences Ltd.'s earnings per share (EPS) over the last twelve months is $-0.01, as of May 2026.
What was Lobe Sciences Ltd.'s earnings per share (EPS) in 2025?
In 2025, Lobe Sciences Ltd.'s earnings per share (EPS) was $-0.02, compared with $-0.03 in 2024.
How has Lobe Sciences Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Lobe Sciences Ltd.'s earnings per share (EPS) was highest in 2025 ($-0.02) and lowest in 2022 ($-0.24).
How does Lobe Sciences Ltd.'s earnings per share (EPS) compare with similar companies?
Lobe Sciences Ltd.'s earnings per share (EPS) ($-0.01) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.